These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 14980386)

  • 1. Long-term effects on cortical glutamate release induced by prenatal exposure to the cannabinoid receptor agonist (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinyl-methyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone: an in vivo microdialysis study in the awake rat.
    Antonelli T; Tanganelli S; Tomasini MC; Finetti S; Trabace L; Steardo L; Sabino V; Carratu MR; Cuomo V; Ferraro L
    Neuroscience; 2004; 124(2):367-75. PubMed ID: 14980386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 and carbon monoxide reduces extracellular glutamate levels in primary rat cerebral cortex cell cultures.
    Antonelli T; Tomasini MC; Tattoli M; Cassano T; Finetti S; Mazzoni E; Trabace L; Carratù MR; Cuomo V; Tanganelli S; Ferraro L
    Neurochem Int; 2006 Nov; 49(6):568-76. PubMed ID: 16777266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cannabinoid receptor agonist WIN 55,212-2 regulates glutamate transmission in rat cerebral cortex: an in vivo and in vitro study.
    Ferraro L; Tomasini MC; Gessa GL; Bebe BW; Tanganelli S; Antonelli T
    Cereb Cortex; 2001 Aug; 11(8):728-33. PubMed ID: 11459762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal exposure to the CB1 receptor agonist WIN 55,212-2 causes learning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changes in rat offspring.
    Antonelli T; Tomasini MC; Tattoli M; Cassano T; Tanganelli S; Finetti S; Mazzoni E; Trabace L; Steardo L; Cuomo V; Ferraro L
    Cereb Cortex; 2005 Dec; 15(12):2013-20. PubMed ID: 15788701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term reduction of brain-derived neurotrophic factor levels and signaling impairment following prenatal treatment with the cannabinoid receptor 1 receptor agonist (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinyl-methyl) pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1- naphthalenylmethanone.
    Maj PF; Collu M; Fadda P; Cattaneo A; Racagni G; Riva MA
    Eur J Neurosci; 2007 Jun; 25(11):3305-11. PubMed ID: 17552998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid receptor agonist WIN 55,212-2 inhibits rat cortical dialysate gamma-aminobutyric acid levels.
    Ferraro L; Tomasini MC; Cassano T; Bebe BW; Siniscalchi A; O'Connor WT; Magee P; Tanganelli S; Cuomo V; Antonelli T
    J Neurosci Res; 2001 Oct; 66(2):298-302. PubMed ID: 11592127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 increases glutamate uptake through overexpression of GLT1 and EAAC1 glutamate transporter subtypes in rat frontal cerebral cortex.
    Castaldo P; Magi S; Gaetani S; Cassano T; Ferraro L; Antonelli T; Amoroso S; Cuomo V
    Neuropharmacology; 2007 Sep; 53(3):369-78. PubMed ID: 17631920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis.
    Köfalvi A; Rodrigues RJ; Ledent C; Mackie K; Vizi ES; Cunha RA; Sperlágh B
    J Neurosci; 2005 Mar; 25(11):2874-84. PubMed ID: 15772347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periaqueductal grey CB1 cannabinoid and metabotropic glutamate subtype 5 receptors modulate changes in rostral ventromedial medulla neuronal activities induced by subcutaneous formalin in the rat.
    de Novellis V; Mariani L; Palazzo E; Vita D; Marabese I; Scafuro M; Rossi F; Maione S
    Neuroscience; 2005; 134(1):269-81. PubMed ID: 15953687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional tolerance and blockade of long-term depression at synapses in the nucleus accumbens after chronic cannabinoid exposure.
    Hoffman AF; Oz M; Caulder T; Lupica CR
    J Neurosci; 2003 Jun; 23(12):4815-20. PubMed ID: 12832502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release.
    Mereu G; Fà M; Ferraro L; Cagiano R; Antonelli T; Tattoli M; Ghiglieri V; Tanganelli S; Gessa GL; Cuomo V
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4915-20. PubMed ID: 12679519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of cannabinoid protection from neuronal excitotoxicity.
    Kim SH; Won SJ; Mao XO; Jin K; Greenberg DA
    Mol Pharmacol; 2006 Mar; 69(3):691-6. PubMed ID: 16299067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling pathways from cannabinoid receptor-1 activation to inhibition of N-methyl-D-aspartic acid mediated calcium influx and neurotoxicity in dorsal root ganglion neurons.
    Liu Q; Bhat M; Bowen WD; Cheng J
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1062-70. PubMed ID: 19752241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoids inhibit sodium-dependent, high-affinity excitatory amino acid transport in cultured rat cortical astrocytes.
    Shivachar AC
    Biochem Pharmacol; 2007 Jun; 73(12):2004-11. PubMed ID: 17445778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SR141716A is an inverse agonist at the human cannabinoid CB1 receptor.
    Landsman RS; Burkey TH; Consroe P; Roeske WR; Yamamura HI
    Eur J Pharmacol; 1997 Sep; 334(1):R1-2. PubMed ID: 9346339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of interleukin-8 release in the human colonic epithelial cell line HT-29 by cannabinoids.
    Ihenetu K; Molleman A; Parsons ME; Whelan CJ
    Eur J Pharmacol; 2003 Jan; 458(1-2):207-15. PubMed ID: 12498928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats.
    Izzo AA; Mascolo N; Pinto L; Capasso R; Capasso F
    Eur J Pharmacol; 1999 Nov; 384(1):37-42. PubMed ID: 10611417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 in endotoxemic mice.
    Smith SR; Terminelli C; Denhardt G
    J Pharmacol Exp Ther; 2000 Apr; 293(1):136-50. PubMed ID: 10734163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in cannabinoid receptor subtype 1 activity and interaction with metabotropic glutamate subtype 5 receptors in the periaqueductal gray-rostral ventromedial medulla pathway in a rodent neuropathic pain model.
    Palazzo E; Luongo L; Bellini G; Guida F; Marabese I; Boccella S; Rossi F; Maione S; de Novellis V
    CNS Neurol Disord Drug Targets; 2012 Mar; 11(2):148-61. PubMed ID: 22483283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a "CB3" receptor.
    Fride E; Foox A; Rosenberg E; Faigenboim M; Cohen V; Barda L; Blau H; Mechoulam R
    Eur J Pharmacol; 2003 Feb; 461(1):27-34. PubMed ID: 12568912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.